Clinical Trial: A Study of the Synergistic Effect of Vebecototumab Combined with Bevacizumab in Conjunction with Re-radiotherapy for the Treatment of Recurrent High-Grade Brain Gliomas (China)

China, Aug. 19 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study of the Synergistic Effect of Vebecototumab Combined with Bevacizumab in Conjunction with Re-radiotherapy for the Treatment of Recurrent High-Grade Brain Gliomas'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130332

Registration Time: 2026/08/18

Type: Interventional study

Primary Sponsor: Anhui Provincial Cancer Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337300

Published by HT Digital Content Services with permission from Health Daily Digest....